专利检索 ap:("Miltenyi Biotec GmbH" OR "XenTech") AND inv:"Aloia, Andrea" 第 1 页

1.

发明公开
SSEA4 and ST3GAL2 as chemotherapeutic drug response biomarkers 审中-公开
标题翻译： SSEA4和ST3GAL2 als Reaktions-Biomarker chemotherapeutister Medikamente

公开(公告)号：EP2927328A1

公开(公告)日：2015-10-07

申请号：EP14305477.3

申请日：2014-04-01

申请人： Miltenyi Biotec GmbH , XenTech

发明人： Hardt, Olaf , Bosio, Andeas , Aloia, Andrea , Judde, Jean-Gabriel , Petrova, Evgeniya , Cairo, Stefano , Deas, Olivier

IPC分类号： C12Q1/68

CPC分类号： G01N33/57492 , C12Q1/6886 , C12Q2600/106 , C12Q2600/118 , C12Q2600/158 , G01N2405/10

摘要： The present invention provides the use of the biomarkers SSEA4 and/or ST3GAL2 for assessing the outcome for chemotherapeutic treatment of a cancer in an individual and methods thereof.

摘要翻译： 本发明提供生物标志物SSEA4和/或ST3GAL2用于评估个体中癌症的化学治疗结果及其方法的用途。

2.

发明授权
SSEA4 and ST3GAL2 as chemotherapeutic drug response biomarkers 有权

公开(公告)号：EP2927328B1

公开(公告)日：2018-10-10

申请号：EP14305477.3

申请日：2014-04-01

申请人： Miltenyi Biotec GmbH , XenTech

发明人： Hardt, Olaf , Bosio, Andeas , Aloia, Andrea , Judde, Jean-Gabriel , Petrova, Evgeniya , Cairo, Stefano , Deas, Olivier

IPC分类号： C12Q1/6886

CPC分类号： G01N33/57492 , C12Q1/6886 , C12Q2600/106 , C12Q2600/118 , C12Q2600/158 , G01N2405/10

摘要： The present invention provides the use of the biomarkers SSEA4 and/or ST3GAL2 for assessing the outcome for chemotherapeutic treatment of a cancer in an individual and methods thereof.